Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07174245

Pregnancy and Postpartum CGM in GDM

Sponsor: Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.

Official title: Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

40

Start Date

2025-08-05

Completion Date

2026-08-15

Last Updated

2025-09-15

Healthy Volunteers

No

Interventions

DEVICE

continuous glucose monitor

All participants who wear CGM

Locations (1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States